Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study

Liang, Yingxiu; Hou, Xiaohong; Chen, Haoying; Yang, Ruqing; Wang, Ruina; Mao, Ruotong; Zhao, Junzhao; Chen, Hui; Cheng, Jing

doi:10.2147/ijwh.s454410

IJWH

2024

DOI: 10.2147/ijwh.s454410

|View full text |Cite

Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study

Yingxiu Liang,

Xiaohong Hou,

Haoying Chen

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 49 publications

(58 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Research Progress on Luteinizing Hormone and Polycystic Ovary Syndrome

Li,

Wang,

Zhang

et al. 2024

JCMP

View full text Add to dashboard Cite

Polycystic ovary syndrome is a common endocrine disease in women of childbearing age, with an incidence of about 6% to 10%, which is the main cause of anovulatory infertility. With the development of assisted reproductive technology, up to 60% of patients with polycystic ovary syndrome need to be pregnant successfully through in vitro fertilization and embryo transfer. Ovarian controlled ovulation induction is an important process in assisted reproductive therapy. Luteinizing hormone plays an important role in the development and maturation of follicles in the ovary, and high levels of luteinizing hormone have a negative effect on pregnancy outcome. at present, it is still controversial that the appropriate level of luteinizing hormone will improve the pregnancy outcome, and the mechanism of how luteinizing hormone affects the pregnancy outcome is still unclear. This article will mainly review the above two aspects in order to provide reference for clinical research in the future.

show abstract

Research Progress on Luteinizing Hormone and Polycystic Ovary Syndrome

Li,

Wang,

Zhang

et al. 2024

JCMP

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study

Cited by 1 publication

References 49 publications

Research Progress on Luteinizing Hormone and Polycystic Ovary Syndrome

Research Progress on Luteinizing Hormone and Polycystic Ovary Syndrome

Contact Info

Product

Resources

About